Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Selective CDK4/6 inhibitor cancer therapeutics

Selective CDK4/6 inhibitor cancer therapeutics

US Patent 11964983 · Granted Apr 23, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Substituted pyrrolo[2,3-d]pyrimidines as selective CDK 4/6 inhibitors2025
Substituted pyrrolo[2,3-d]pyrimidines as selective CDK 4/6 inhibitors2025
Substituted pyrrolo[2,3-d]pyrimidines as selective CDK 4/6 inhibitors2025
Selective CDK 4/6 inhibitor cancer therapeutics2025
Selective CDK 4/6 inhibitor cancer therapeutics2025
Selective CDK 4/6 inhibitor cancer therapeutics2025
Azithromycin and roxithromycin derivtives as senolytic drugs2025
Azithromycin and roxithromycin derivtives as senolytic drugs2025
Biomarkers and therapeutics for endocrine therapy resistance2025
Biomarkers and therapeutics for endocrine therapy resistance2025
Companion diagnostics for mitochondrial inhibitors2024
Companion diagnostics for mitochondrial inhibitors2024